| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +37.5K | +30.58% | $0.00 | 160K | Feb 24, 2023 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$679K | -2.31K | -1.44% | $294.27 | 158K | Feb 24, 2023 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$5.12M | -17.4K | -11.01% | $294.27 | 141K | Feb 24, 2023 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | -$5.92M | -20.1K | -14.33% | $294.06 | 120K | Feb 27, 2023 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1.7K | Feb 24, 2023 | By 401(k) | F5 | |||||
| holding | CI | Common Stock, $.01 Par Value | 377K | Feb 24, 2023 | By GRAT | ||||||
| holding | CI | Common Stock, $.01 Par Value | 90.5K | Feb 24, 2023 | By Trust |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14 , 2022. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |